Drug interactions in maternal intensive care: prevalence, risk factors, and potential risk medications

ABSTRACT Objective: To characterize severe potential drug interactions in maternal intensive care, and to determine their frequency, risk factors and potential risk medications. Methods: An observational and longitudinal study conducted between December 2014 and December 2015 in a maternal intensi...

Full description

Bibliographic Details
Main Authors: Thiago de Lima Pessoa, Washington Sales Clemente Junior, Tatiana Xavier da Costa, Priscilla Karilline do Vale Bezerra, Rand Randall Martins
Format: Article
Language:English
Published: Instituto Israelita de Ensino e Pesquisa Albert Einstein
Series:Einstein (São Paulo)
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082019000300203&lng=en&tlng=en
id doaj-875ef6a5c9c84153af3c04c20cbfb497
record_format Article
spelling doaj-875ef6a5c9c84153af3c04c20cbfb4972020-11-25T00:55:17ZengInstituto Israelita de Ensino e Pesquisa Albert EinsteinEinstein (São Paulo)2317-638517310.31744/einstein_journal/2019ao4521S1679-45082019000300203Drug interactions in maternal intensive care: prevalence, risk factors, and potential risk medicationsThiago de Lima PessoaWashington Sales Clemente JuniorTatiana Xavier da CostaPriscilla Karilline do Vale BezerraRand Randall MartinsABSTRACT Objective: To characterize severe potential drug interactions in maternal intensive care, and to determine their frequency, risk factors and potential risk medications. Methods: An observational and longitudinal study conducted between December 2014 and December 2015 in a maternal intensive care unit. Clinical data were collected and severe potential drug interactions were identified on pregnant inpatients. The drug interactions were classified by type, prevalence and exposure rate. A multivariate logistic regression model was used to identify the severe potential drug interactions and the related drugs (p<0.05). Results: A total of 95.1% of patients were exposed to, at least, one potential drug interaction; in that, 91.7% 33.9% were related to, respectively, moderate and severe potential drug interactions. The patients were exposed, on average, on 69.2% of days they were in the intensive care unit. The main drugs involved in more severe drug interactions were magnesium sulfate, metoclopramide, propranolol and diazepam. Conclusion: The severe potential drug interactions were observed in almost all patients of the study, and, approximately one third of those interactions were related to greater severity and resulted in exposure during long hospital stay. The higher number of prescribed drugs and its previous use of medications at home increase the occurrence of severe potential drug interactions.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082019000300203&lng=en&tlng=enInterações de medicamentosUnidade de terapia intensivaSaúde maternaTratamento farmacológicoGravidez
collection DOAJ
language English
format Article
sources DOAJ
author Thiago de Lima Pessoa
Washington Sales Clemente Junior
Tatiana Xavier da Costa
Priscilla Karilline do Vale Bezerra
Rand Randall Martins
spellingShingle Thiago de Lima Pessoa
Washington Sales Clemente Junior
Tatiana Xavier da Costa
Priscilla Karilline do Vale Bezerra
Rand Randall Martins
Drug interactions in maternal intensive care: prevalence, risk factors, and potential risk medications
Einstein (São Paulo)
Interações de medicamentos
Unidade de terapia intensiva
Saúde materna
Tratamento farmacológico
Gravidez
author_facet Thiago de Lima Pessoa
Washington Sales Clemente Junior
Tatiana Xavier da Costa
Priscilla Karilline do Vale Bezerra
Rand Randall Martins
author_sort Thiago de Lima Pessoa
title Drug interactions in maternal intensive care: prevalence, risk factors, and potential risk medications
title_short Drug interactions in maternal intensive care: prevalence, risk factors, and potential risk medications
title_full Drug interactions in maternal intensive care: prevalence, risk factors, and potential risk medications
title_fullStr Drug interactions in maternal intensive care: prevalence, risk factors, and potential risk medications
title_full_unstemmed Drug interactions in maternal intensive care: prevalence, risk factors, and potential risk medications
title_sort drug interactions in maternal intensive care: prevalence, risk factors, and potential risk medications
publisher Instituto Israelita de Ensino e Pesquisa Albert Einstein
series Einstein (São Paulo)
issn 2317-6385
description ABSTRACT Objective: To characterize severe potential drug interactions in maternal intensive care, and to determine their frequency, risk factors and potential risk medications. Methods: An observational and longitudinal study conducted between December 2014 and December 2015 in a maternal intensive care unit. Clinical data were collected and severe potential drug interactions were identified on pregnant inpatients. The drug interactions were classified by type, prevalence and exposure rate. A multivariate logistic regression model was used to identify the severe potential drug interactions and the related drugs (p<0.05). Results: A total of 95.1% of patients were exposed to, at least, one potential drug interaction; in that, 91.7% 33.9% were related to, respectively, moderate and severe potential drug interactions. The patients were exposed, on average, on 69.2% of days they were in the intensive care unit. The main drugs involved in more severe drug interactions were magnesium sulfate, metoclopramide, propranolol and diazepam. Conclusion: The severe potential drug interactions were observed in almost all patients of the study, and, approximately one third of those interactions were related to greater severity and resulted in exposure during long hospital stay. The higher number of prescribed drugs and its previous use of medications at home increase the occurrence of severe potential drug interactions.
topic Interações de medicamentos
Unidade de terapia intensiva
Saúde materna
Tratamento farmacológico
Gravidez
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082019000300203&lng=en&tlng=en
work_keys_str_mv AT thiagodelimapessoa druginteractionsinmaternalintensivecareprevalenceriskfactorsandpotentialriskmedications
AT washingtonsalesclementejunior druginteractionsinmaternalintensivecareprevalenceriskfactorsandpotentialriskmedications
AT tatianaxavierdacosta druginteractionsinmaternalintensivecareprevalenceriskfactorsandpotentialriskmedications
AT priscillakarillinedovalebezerra druginteractionsinmaternalintensivecareprevalenceriskfactorsandpotentialriskmedications
AT randrandallmartins druginteractionsinmaternalintensivecareprevalenceriskfactorsandpotentialriskmedications
_version_ 1725230932120567808